2014 Taiwan Digestive Disease Week, TDDW
International Taiwan-Korea Forum of Viral Hepatitis

Date: October 4, 2014（Saturday）13:30-15:30
Venue: Kaohsiung Exhibition Center Conference Room E
Time Topic Speaker Monderator
Opening Remarks Rong-Nan Chien President, TASL
Kwang-Hyub Han President, KASL
Epidemiology of HBV and HCV Infection in Taiwan

Yi-Cheng Chen

Linkou Chang-Gung Memorial Hospital

Han-Chieh Lin

Taipei Veterans General Hospital

Dong Joon Kim
Epidemiology of HBV and HCV Infection in Korea

Do Young Kim

Yonsei University College of Medicine, Seoul, Korea
Current Status of HBV Treatment in Taiwan - Interferon Based

Cheng-Yuan Peng

China Medical University Hospital
Current Status of HBV Treatment in Taiwan - Nucleos(t)ide Analogues Based

Chun-Jen Liu

National Taiwan University Hospital
The Efficacy and Safety of Peginterferon-α-2a in Korean Patients with Chronic Hepatitis B: A Multicenter Study Conducted in a Real Clinical Setting

Young Seok Kim

SoonChunHyang University Buchen Hospital
Current Status of HBV Treatment in Korea - Nucleos(t)ide Analogues Based

Jin-Wook Kim

Seoul National University Bundang Hospital
Current Status of HCV Treatment in Taiwan

Ming-Lung Yu

Kaohsiung Medical University Hospital

Wan-Long Chuang

Kaohsiung Medical University Hospital

Seung Kew Yoon
The Catholic University of Korea
14:50-15:05 The Virological Response in Koreans Infected with HCV Genotype 1 Did Not Differ between Groups Treated with a Full Dose or Reduced Dose ( 80% Full Dose) of Peginterferon alfa-2a: A Prospective Randomized Multicenter Trial

Si Hyun Bae

The Catholic University of Korea
15:05-15:15 Long-term Outcome of Antiviral Therapy in Taiwan

Yi-Hsiang Huang

Taipei Veterans General Hospital
15:15-15:25 Long-term Outcome of Antiviral Therapy in Korea

Young Suk Lim

Asan Medical Center, Korea
15:25-15:30 Recap and Closing Remarks

Yun-Fan Liaw

Chang-Gung University College of Medicine